• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:王卓,李娴静,冷雪娇.小鼠髓源性树突状细胞分离培养及鉴定[J].药学研究,2023,42(2):89-94[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2769次   下载 2754次 本文二维码信息
码上扫一扫!
小鼠髓源性树突状细胞分离培养及鉴定
王卓1,李娴静2,冷雪娇1
字体:加大+|默认|缩小-
(1.南京中医药大学药学院,江苏 南京 210023;2.中国药科大学药物科学研究院,江苏 南京 211198)
摘要:
目的 建立小鼠髓源性树突状细胞分离培养及鉴定方法。方法 取小鼠股骨和胫骨骨髓细胞,使用重组粒细胞-巨噬细胞集落刺激因子(recombinant granulocyte-macrophage colony-stimulating factor,rmGM-CSF)20 ng·mL-1联合白细胞介素-4(interleukin 4,IL-4)10 ng·mL-1诱导小鼠骨髓前体细胞分化为树突状细胞(dendritic cell)。体外培养10 d,使用流式细胞术鉴定细胞表面树突细胞特异性标志物CD11c、MHCⅡ、CD80、CD86、CD40及CCR7的表达。进一步使用OVA257-264多肽处理细胞48小时,流式细胞术分析该多肽与MHC I形成的复合物的表达,验证该细胞的抗原提呈功能。结果 依据本文方法,培养第10天每只小鼠可获得1.5Í107~2Í107个细胞。其中,38.4%细胞表达CD11c,CD11c阳性的细胞中有15.2%细胞表达MHCⅡ、32.3%细胞表达CD80、7.22%细胞表达CD86,但CD11c阳性的细胞中CD40阳性细胞仅4.15%,CCR7阳性细胞仅1.83%。LPS刺激24 h后,58.1%细胞表达CD11c,CD11c阳性的细胞中有39.8%细胞表达MHCⅡ、38.6%细胞表达CD80、43.1%细胞表达CD86,30.2%细胞表达CD40,10.2%细胞表达CCR7。使用该方法培养的树突细胞具有较强的抗原提呈能力。结论 本试验成功建立体外培养树突细胞的方法,可为基于树突细胞的基础研究和转化应用提供实验基础。
关键词:  小鼠骨髓细胞  树突状细胞  鉴定
DOI:10.13506/j.cnki.jpr.2023.02.003
基金项目:国家自然科学基金(No.82003288)
出版日期:2023-02-25
Isolation, culture and identification of mouse bone marrow derived dendritic cells
WANG Zhuo1,LI Xianjing2,LENG Xuejiao1
(1.School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China;2. Institute of Pharmaceutical Science, China Pharmaceutical University, Nanjing 211198, China)
Abstract:
Objective To establish the isolation, culture and identification method of mouse bone marrow derived dendritic cells. Methods Bone marrow cells from murine femoral and tibial were taken, and the recombinant granulocyte-macrophage colony-stimulating factor(rmGM-CSF)20 ng·mL-1 and interleukin-4 (IL-4) 10 ng·mL-1 was added to induce the mouse myeloid precursor cells differentiates into dendritic cells (DC). The mouse myeloid precursor cells were cultured for 10 days, and then they were used to identify the expression of CD11c, MHC II, CD80, CD86, CD40, and CCR7 by flow cytometry. The cultured cells were further treated with OVA257-264 polypeptide for 48 hours, and the expression of the complexes consisting of OVA257-264 polypeptide and MHC I were detected, verifying the antigen presentation function of the cultured cells. Results According to the described method, 1.5 Í107 to 2Î107 cells per mouse were obtained on day 10. Through this method, 38.4% of the cells expressed CD11c, and among CD11c positive cells, 15.2% expressed MHC Ⅱ, 32.3% expressed CD80 and 7.22% expressed CD86, while the CD11c-positive cells contained only 4.15% of CD40 and 1.83% of CCR7 positive cells. After 24 h of LPS treatment, 58.1% of the total cells expressed CD11c, and the positive rate of MHCII, CD80, CD86, CD40 and CCR7 among CD11c expressed cells was 39.8%, 38.6%, 43.1%, 30.2% and 10.2% respectively. Functional analysis reveal that the cultured cells showed a strong antigen presentation capacity.Conclusion These experiment successfully established the method for DC culture in vitro, which can provide an experimental basis for the basic research and transformation application based on DCs.
Key words:  Mouse myeloid precursor cells  Dendritic cells  Identification
今日访问量:2328    总访问量:55338696
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司